Zobrazeno 1 - 10
of 1 534
pro vyhledávání: '"M Lazdunski"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hervé Quintard, J. Veyssiere, H. Moha Ou Maati, C. Gandin, B. Onteniente, Catherine Heurteaux, M Lazdunski, Marc Borsotto, Catherine Widmann
Publikováno v:
Cerebrovascular Diseases. 35:1-7
Background: Treatments for stroke and other brain injuries are limited. NeuroAiD has been shown to be beneficial in clinical studies. We reviewed the pharmacological effects of NeuroAiD on the normal and ischemic brain and neurons. Methods: In vivo a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708f58f61e4c8a980eeab6588fe176d3
https://doi.org/10.1159/000346228
https://doi.org/10.1159/000346228
Autor:
Fabien Labbal, M Lazdunski, J. Veyssiere, Hervé Quintard, Marc Borsotto, Catherine Heurteaux, C. Gandin, Catherine Widmann
Publikováno v:
Neuropharmacology
Neuropharmacology, Elsevier, 2011, 61 (4), pp.622-31. ⟨10.1016/j.neuropharm.2011.05.003⟩
Neuropharmacology, Elsevier, 2011, 61 (4), pp.622-31. ⟨10.1016/j.neuropharm.2011.05.003⟩
International audience; Global ischemia leads to damage in the hippocampal CA1 region and is associated with behavioral deficits. NeuroAid (MLC601 and MLC901), a Traditional Chinese Medicine is used in China for patients after stroke. We have investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c6e8e043d77f51b70011ef792b88bc9
https://doi.org/10.1016/j.neuropharm.2011.05.003
https://doi.org/10.1016/j.neuropharm.2011.05.003
Autor:
B. Onteniente, M. Lhuillier, Catherine Widmann, Marc Borsotto, Catherine Heurteaux, M Lazdunski, C. Gandin, Frédéric Brau
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2010, 58 (7), pp.987-1001. ⟨10.1016/j.neuropharm.2010.01.001⟩
Oncogene, 2010, 58 (7), pp.987-1001. ⟨10.1016/j.neuropharm.2010.01.001⟩
Oncogene, Nature Publishing Group, 2010, 58 (7), pp.987-1001. ⟨10.1016/j.neuropharm.2010.01.001⟩
Oncogene, 2010, 58 (7), pp.987-1001. ⟨10.1016/j.neuropharm.2010.01.001⟩
International audience; Although stroke remains a leading cause of death and adult disability, numerous recent failures in clinical stroke trials have led to some pessimism in the field. Interestingly, NeuroAid (MLC601), a traditional medicine, parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe7d26917298868c030872cc84a168a7
https://doi.org/10.1016/j.neuropharm.2010.01.001
https://doi.org/10.1016/j.neuropharm.2010.01.001
Publikováno v:
Douleur et Analgésie. 21:215-220
TREK-1 (TWIK1-related K+channel) est l’un des membres de la famille des canaux potassium a deux domaines P (K2P). C’est un canal qui est sensible a la temperature, aux contraintes mecaniques et osmotiques et qui est regule par des recepteurs coup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::543107bc972f2dea17eb834537f23fbb
https://doi.org/10.1007/s11724-008-0108-1
https://doi.org/10.1007/s11724-008-0108-1
Publikováno v:
Journal of Neuroscience Research
MLC901 (NurAiDII) is used as a treatment for stroke patients. It has been shown that MLC901 improves motor and cognitive recovery in ischemic and traumatic brain‐injured rodents. The present study seeks to delineate cognitive effects induced by MLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d9a0ad8c3e972c6221d44325158fb12
https://pubmed.ncbi.nlm.nih.gov/25821139
https://pubmed.ncbi.nlm.nih.gov/25821139
Publikováno v:
The Journal of Physiology. 562:235-244
This study firstly shows with in situ hybridization on human pancreas that TALK-1 and TALK-2, two members of the 2P domain potassium channel (K2P) family, are highly and specifically expressed in the exocrine pancreas and absent in Langherans islets.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98478641760675f90337e7a7b24d54a9
https://doi.org/10.1113/jphysiol.2004.071266
https://doi.org/10.1113/jphysiol.2004.071266
Publikováno v:
Neuroscience
Neuroscience, Elsevier-International Brain Research Organization, 2002, 109, pp.231-241
Neuroscience, Elsevier-International Brain Research Organization, 2002, 109 (2), pp.231-241. ⟨10.1016/s0306-4522(01)00473-0⟩
Neuroscience, Elsevier-International Brain Research Organization, 2002, 109, pp.231-241
Neuroscience, Elsevier-International Brain Research Organization, 2002, 109 (2), pp.231-241. ⟨10.1016/s0306-4522(01)00473-0⟩
International audience; The fndings reported in this work show that pretreatment with polyunsaturated fatty acids, particularly linolenic acid, present in vegetable oils, can provide a potent tolerance against neurodegeneration in two models of neuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845372d162e89a1b521b01ff4ed2f93b
https://doi.org/10.1016/s0306-4522(01)00473-0
https://doi.org/10.1016/s0306-4522(01)00473-0
Autor:
Catherine Widmann, H. Moha Ou Maati, Marc Borsotto, F. Chatelain, M Lazdunski, Catherine Heurteaux
Publikováno v:
Neuropharmacology
Neuropharmacology, Elsevier, 2012, 63 (4), pp.692-700. ⟨10.1016/j.neuropharm.2012.05.035⟩
Neuropharmacology, Elsevier, 2012, 63 (4), pp.692-700. ⟨10.1016/j.neuropharm.2012.05.035⟩
International audience; NeuroAid (MLC601 and MLC901), a Traditional Medicine used in China for patients after stroke has been reported in preclinical models of ischemia to induce neuroprotection and neuroplasticity. This work shows the effects of MLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64db068f8ce39a6a357090e6ad0647ff
https://hal.archives-ouvertes.fr/hal-00726295
https://hal.archives-ouvertes.fr/hal-00726295
